TG Therapeutics Inc (TGTX) — Cash Flow Quality Index
Latest as of June 2026:
0.78x
TG Therapeutics Inc (TGTX) has a Cash Flow Quality Index of 0.78x as of June 2026. Operating cash flow of $21.37 Million is below net income of $27.56 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore TG Therapeutics Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
0.78x
Operating CF / Net Income
Operating Cash Flow
$21.37 Million
USD
Net Income
$27.56 Million
USD
Data as of
Jun 2026
Most recent filing
TG Therapeutics Inc Cash Flow Quality Index (2010–2025)
Historical Cash Flow Quality Index for TG Therapeutics Inc across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see TGTX cash flow conversion.
Annual Cash Flow Quality Index for TG Therapeutics Inc (2010–2025)
Year-by-year earnings quality comparison for TG Therapeutics Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -0.06x | $-24.77 Million | $447.18 Million | ▲ +96.8% |
| 2024 | -1.73x | $-40.52 Million | $23.38 Million | ▲ +30.1% |
| 2023 | -2.48x | $-31.41 Million | $12.67 Million | ▲ +21.5% |
| 2010 | -3.16x | $-1.97 Million | $623.64K | — |
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.